KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Total Debt (2017 - 2025)

Astrana Health's Total Debt history spans 14 years, with the latest figure at $47.9 million for Q3 2025.

  • For Q3 2025, Total Debt fell 89.07% year-over-year to $47.9 million; the TTM value through Sep 2025 reached $47.9 million, down 89.07%, while the annual FY2024 figure was $434.7 million, 56.11% up from the prior year.
  • Total Debt for Q3 2025 was $47.9 million at Astrana Health, up from $12.5 million in the prior quarter.
  • Across five years, Total Debt topped out at $442.0 million in Q2 2024 and bottomed at $621000.0 in Q1 2023.
  • The 5-year median for Total Debt is $204.0 million (2022), against an average of $234.0 million.
  • The largest annual shift saw Total Debt plummeted 99.66% in 2023 before it skyrocketed 62572.79% in 2024.
  • A 5-year view of Total Debt shows it stood at $183.7 million in 2021, then grew by 11.06% to $204.0 million in 2022, then skyrocketed by 36.48% to $278.4 million in 2023, then soared by 56.11% to $434.7 million in 2024, then tumbled by 88.99% to $47.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Total Debt are $47.9 million (Q3 2025), $12.5 million (Q2 2025), and $403.9 million (Q1 2025).